Company Overview Merck Group Focused on today, positioned for tomorrow Since the creation of our new division in January 2007, Merck Serono has laid the foundations for its future success. Today, we have a common vision, federating values and a clear strategy in place to achieve our business objectives. We are committed to growing our business in specialist therapeutic areas where our knowledge and experience can make a real difference for patients. We will achieve this through our own research and development as well through partnerships, which are an integral part of our strategy. Today, our integrated and optimized R&D portfolio combines the strengths of two complementary businesses, and the result is greater than the sum of the parts. It reflects our rich heritage of pharmaceutical chemistry and biological expertise and provides a broad technological platform for innovation. A unique force in the pharmaceutical industry Merck Serono combines its complementary expertise in new chemical entities (NCEs) and new biological entities (NBEs) to offer innovative prescription drugs of either origin. With comprehensive skills in all areas from research and development to manufacturing, marketing and sales, the division offers its world-class products in over 150 countries worldwide. Our strategically positioned workforce of 8,000 sales and marketing employees ensures commercial coverage in the U.S. and Canada, Latin America, Europe, Asia-Pacific and Japan.
|
